Your browser doesn't support javascript.
loading
Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: A systematic review.
Aylward, Conor; Noori, Jawed; Tyrrell, Jack; O'sullivan, Niall; Kavanagh, Dara O; Larkin, John O; Mehigan, Brian J; McCormick, Paul H; Kelly, Michael E.
Afiliação
  • Aylward C; National University Ireland Galway, Galway, Ireland.
  • Noori J; Royal Perth Hospital, Western Australia, Perth, Australia.
  • Tyrrell J; Peter MaCallum Cancer Centre, Victoria, Melbourne, Australia.
  • O'sullivan N; Fiona Stanley Hospital, Western Australia, Perth, Australia.
  • Kavanagh DO; University Hospital Galway, Galway, Ireland.
  • Larkin JO; Tallaght University Hospital, Dublin, Ireland.
  • Mehigan BJ; St James's Hospital, Dublin, Ireland.
  • McCormick PH; St James's Hospital, Dublin, Ireland.
  • Kelly ME; St James's Hospital, Dublin, Ireland.
J Surg Oncol ; 127(4): 645-656, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36350234
ABSTRACT

BACKGROUND:

Synchronous para-aortic lymph node metastasis (PALNM) in colorectal cancer (CRC) is a relatively rare clinical entity. There is a lack of consensus on management of these patients, and the role of para-aortic lymph node dissection (PALND) remains controversial. This systematic review aims to describe the survival outcomes in colorectal cancer with synchronous PALNM when lymph node dissection is performed.

METHODS:

A systematic review of Pubmed, Embase and Web of Science databases for PALND in CRC was performed. Studies including patients with synchronous PALNM undergoing resection with curative intent, published from the year 2000 onwards, were included.

RESULTS:

Twelve retrospective studies were included. Four studies reported survival outcomes for rectal cancer, two for colon cancer and six as colorectal. Survival outcomes for 356 patients were included. Average 5-year overall survival (OS) was 22.4%, 33.9% and 37.7% in the rectal, colon and colorectal groups respectively. Three year OS in the groups was 53.6%, 46.2% and 65.7%.

CONCLUSION:

There remains a lack of quality data to confidently make recommendations regarding the management of synchronous PALNM in colon and rectal cancer cohorts. Retrospective data suggests a benefit in highly selective cohorts and therefore a case-by-case evaluation remains the standard of care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias do Colo Tipo de estudo: Guideline / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias do Colo Tipo de estudo: Guideline / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda